The Korean Journal of Clinical Laboratory Science : eISSN 2288-1662 / pISSN 1738-3544

Table. 2.

Table. 2.

Antimicrobial susceptibilities of 33 E. coli strains isolated from clinical specimens

Antimicrobial agent No (%) of clinical specimens*

Susceptible Intermediate resistant Resistant
Amikacin 4 (12.1) 27 (81.8) 2 (6.1)
Gentamicin 14 (42.4) 2 (6.1) 17 (51.5)
Tobramycin 13 (39.4) 3 (9.01) 17 (51.5)
Spectinomycin 24 (72.7) 8 (24.2) 1 (3.0)
Streptomycin 0 (0.0) 6 (18.2) 27 (81.8)
Ampicillin 0 (0.0) 0 (0.0) 33 (100.0)
Cefotaxime 11 (33.3) 4 (12.1) 18 (54.5)
Levofloxacin 12 (36.4) 1 (3.0) 20 (60.6)
Ciprofloxacin 9 (27.3) 4 (12.1) 20 (60.6)
Trimethoprim 12 (36.4) 0 (0.0) 21 (63.6)

*The results were obtained from antimicrobial susceptibility tests were performed on 33 aminoglycoside non-susceptible E. coli isolated from clinical specimens in Chungcheong province.

Korean J Clin Lab Sci 2020;52:136-42 https://doi.org/10.15324/kjcls.2020.52.2.136
© 2020 Korean J Clin Lab Sci